The posterior tibial tendon (PTT) is very vulnerable and insufficiency was recognized as the major cause of adult acquired flat foot. Some patients have no predisposing cause clinically recognized, showing that the characteristics of the individual plays an important role in tendinopathy. This study investigated whether genetic variants in matrix metalloproteinase (MMP) are associated with dysfunction PTT.
METHOD
One hundred women who served dysfunction PTT, the histopathological examination of the tendons and magnetic resonance imaging (MRI) confirms tendinopathy, and 100 women without symptoms who PPT intact as assessed by MRI and a control group, were evaluated for MMP-13 G-77 A> > G (rs2252070) polymorphism, individually and in haplotypes, as well as in combination with MMP-1 G-519 A >> G (rs1144393), MMP-1 G-1607 G >> GG (rs1799750) and MMP-8 G. 799 C >> T (rs11225395) polymorphism with PTT dysfunction.
RESULTS
The frequency of allele A (MMP-13 G-77 A >> G (rs2252070) polymorphism) was significantly higher in case group (76% and 61%, respectively; p = 0.010, odds ratio = 2.02; 95 % confidence interval = 1.32 to 3.12). The distribution of genotypes also differed significantly between groups (p = 0.001, odds ratio = 2.82; 95% confidence interval = 1.58 to 5.02). global haplotype analysis showed a significant difference between the two groups.
CONCLUSION
In conclusion, these findings suggest that MMP-13 G-77 A >> G (rs2252070) polymorphism individually, as well as haplotypes MMP-1 G-519 A >> G (rs1144393), MMP-1 g.- 1607 G> > GG (rs1799750) and MMP-8 G-799 C >> T (rs11225395), can cause dysfunction PTT.

NanoSim: sequence based nanopore reading simulator statistical characterization.
The Minion sequencing instrument of Oxford Nanopore Technologies (ONT) produces long read length of single-molecule sequencing – a valuable feature for a detailed characterization of the genome. To realize the potential of this platform, a number of groups that develop bioinformatics tools tuned to the unique characteristics of the data. We note that these development efforts will benefit from the software simulator, the output can be used to benchmark analysis tools.
Here, we introduce NanoSim, fast and scalable read simulator that captures a specific technology ONT data features and allows for adjustments to the improvement of nanopore sequencing technology. The first step is to read the NanoSim characterization, which provides a comprehensive analysis of the alignment-based and generates a set of read profile serves as the input for the next step, the simulation stage. Phase simulations using a model built in the previous step to generate in silico reading for a given reference genome. NanoSim written in Python and R.
Recombinant Proteus mirabilis Beta-lactamase (blaP) |
MBS1130494-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1100 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLM-associated Protein of 75 kDa, BLAP75, C9orf76, FAAP75, RP11-346I8.1) |
MBS644630-005mg |
MyBiosource |
0.05mg |
EUR 630 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLM-associated Protein of 75 kDa, BLAP75, C9orf76, FAAP75, RP11-346I8.1) |
MBS644630-5x005mg |
MyBiosource |
5x0.05mg |
EUR 2680 |
BLAP75 (RMI1) (NM_024945) Human Recombinant Protein |
E45H38254M5 |
EnoGene |
20 ug |
EUR 785.42 |
BLAP75 (RMI1) (NM_024945) Human Recombinant Protein |
PROTQ9H9A7 |
BosterBio |
20ug |
EUR 1249 |
Description: Purified recombinant protein of Homo sapiens RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae) (RMI1) |
BLAP75 (RMI1) (NM_024945) Human Over-expression Lysate |
E45H12255-2 |
EnoGene |
each |
EUR 395 |
BLAP75 (RMI1) (NM_024945) Human Over-expression Lysate |
LS080010 |
BosterBio |
100ug |
EUR 628 |
|
Description: Transient overexpression lysate of RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae) (RMI1) |
NubO (68–75), Ndufa4 (68–75) |
5-01645 |
CHI Scientific |
4 x 5mg |
EUR 180.18 |
Description: Val-Asn-Val-Asp-Tyr-Ser-Lys-Leu |
PIK-75 |
A2080-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 48.8 |
|
Description: PI3K/Akt/mTOR Signaling|PI3K |
C 75 |
A4449-10 |
ApexBio |
10 mg |
EUR 251.2 |
|
Description: Apoptosis|Apoptosis Inducers |
C 75 |
A4449-5 |
ApexBio |
5 mg |
EUR 152 |
|
Description: Apoptosis|Apoptosis Inducers |
C 75 |
A4449-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 297.6 |
Description: C 75 is an inhibitor of fatty acid synthase [1]. Fatty acid synthase (FAS) is a multi-enzyme protein that catalyzes fatty acid synthesis. Its main function is to catalyze the synthesis of palmitate from acetyl-CoA and malonyl-CoA. |
C 75 |
A4449-50 |
ApexBio |
50 mg |
EUR 1062.4 |
|
Description: Apoptosis|Apoptosis Inducers |
PIK-75 |
HY-107834 |
MedChemExpress |
Get quote |
Ask for price |
Description: PIK-75 is a reversible DNA-PK and p110α-selective inhibitor, which inhibits DNA-PK, p110α and p110γ with IC50s of 2, 5.8 and 76 nM, respectively. PIK-75 inhibits p110α >200-fold more potently than p110β (IC50=1.3 μM)[1][2]. PIK-75 induces apoptosis[3]. |
NubO (68–75), Ndufa4 (68–75) Peptide |
abx265976-100tests |
Abbexa |
100 tests |
EUR 250 |
NubO (68–75), Ndufa4 (68–75) Peptide |
20-abx265976 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
|
NubO (68–75), Ndufa4 (68–75) Peptide |
abx265976-200tests |
Abbexa |
200 tests |
EUR 337.5 |
NubO (68–75), Ndufa4 (68–75) Peptide |
abx265976-500tests |
Abbexa |
500 tests |
EUR 575 |
75 cm2 Nunc T-75 Flask Holder |
LBI10238 |
Westburg |
each |
EUR 235.44 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (AP) |
MBS6435714-01mL |
MyBiosource |
0.1mL |
EUR 950 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (AP) |
MBS6435714-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4120 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (PE) |
MBS6435724-01mL |
MyBiosource |
0.1mL |
EUR 950 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (PE) |
MBS6435724-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4120 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (APC) |
MBS6435715-01mL |
MyBiosource |
0.1mL |
EUR 950 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (APC) |
MBS6435715-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4120 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (FITC) |
MBS6435717-01mL |
MyBiosource |
0.1mL |
EUR 950 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (FITC) |
MBS6435717-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4120 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (HRP) |
MBS6435718-01mL |
MyBiosource |
0.1mL |
EUR 950 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (HRP) |
MBS6435718-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4120 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (Biotin) |
MBS6435716-01mL |
MyBiosource |
0.1mL |
EUR 950 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (Biotin) |
MBS6435716-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4120 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 405) |
MBS6435719-01mL |
MyBiosource |
0.1mL |
EUR 950 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 405) |
MBS6435719-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4120 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 490) |
MBS6435720-01mL |
MyBiosource |
0.1mL |
EUR 950 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 490) |
MBS6435720-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4120 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 550) |
MBS6435721-01mL |
MyBiosource |
0.1mL |
EUR 950 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 550) |
MBS6435721-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4120 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 650) |
MBS6435722-01mL |
MyBiosource |
0.1mL |
EUR 950 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 650) |
MBS6435722-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4120 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 750) |
MBS6435723-01mL |
MyBiosource |
0.1mL |
EUR 950 |
RMI1 (RecQ-mediated Genome Instability Protein 1, BLAP75, FAAP75, C9orf76) (MaxLight 750) |
MBS6435723-5x01mL |
MyBiosource |
5x0.1mL |
EUR 4120 |
Antileukoproteinase 1 (75-89) / SLPI (75-89) (Human) |
002-97 |
PHOENIX PEPTIDE |
100 μg |
EUR 160.92 |
Musclin (39-75) / Osteocrin (Ostn) (39-75) (Mouse) |
028-71 |
PHOENIX PEPTIDE |
100 μg |
EUR 282.96 |
75 cm2 BD/Greiner T-75 Flask Holder |
LBI10240 |
Westburg |
each |
EUR 418.56 |
PIK-75 HCl |
A2080-10 |
ApexBio |
10 mg |
EUR 40 |
|
Description: PI3K/Akt/mTOR Signaling|PI3K |
PIK-75 HCl |
A2080-100 |
ApexBio |
100 mg |
EUR 144 |
|
Description: PI3K/Akt/mTOR Signaling|PI3K |
PIK-75 HCl |
A2080-50 |
ApexBio |
50 mg |
EUR 104 |
|
Description: PI3K/Akt/mTOR Signaling|PI3K |
Cytokeratin 75 antibody |
70R-3038 |
Fitzgerald |
50 ug |
EUR 467 |
|
Description: Rabbit polyclonal Cytokeratin 75 antibody raised against the N terminal of KRT75 |
Cytokeratin 75 antibody |
70R-3039 |
Fitzgerald |
50 ug |
EUR 467 |
|
Description: Rabbit polyclonal Cytokeratin 75 antibody raised against the middle region of KRT75 |
ZR-75-1 |
ABC-TC1310 |
AcceGen |
1 vial |
Ask for price |
Description: The cells produce high levels of MUC-1 mucin mRNA, low levels of MUC-2 mRNA but do not express the MUC-3 gene. |
ZR-75-30 |
ABC-TC1311 |
AcceGen |
1 vial |
Ask for price |
Description: ZR-75-30 was derived from malignant ascites fluid from a 47-year-old premenopausal Black woman with infiltrating ductal carcinoma. These cells have been characterized to be human, non-HeLa, malignant mammary epithelium in origin. |
ND-75 Antibody |
1-CSB-PA821986LA01DLU |
Cusabio |
-
Ask for price
-
Ask for price
|
|
|
Description: A polyclonal antibody against ND-75. Recognizes ND-75 from Drosophila melanogaster. This antibody is Unconjugated. Tested in the following application: ELISA |
col-75 Antibody |
CSB-PA600251XA01CXY-02mg |
Cusabio |
0.2mg |
Ask for price |
|
Description: Recombinant Caenorhabditis elegans col-75 protein |
col-75 Antibody |
CSB-PA600251XA01CXY-10mg |
Cusabio |
10mg |
Ask for price |
|
Description: Recombinant Caenorhabditis elegans col-75 protein |
HSP 75 Antibody |
C30876-100ul |
Assay Biotech |
100μl |
EUR 217 |
Description: HSP 75 Rabbit Polyclonal Antibody |
HSP 75 Antibody |
C30876-50ul |
Assay Biotech |
50μl |
EUR 143.5 |
Description: HSP 75 Rabbit Polyclonal Antibody |
ND-75 Antibody |
abx300635-100g |
Abbexa |
100 µg |
EUR 362.5 |
ND-75 Antibody |
20-abx300635 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
ND-75 Antibody |
abx300635-20g |
Abbexa |
20 µg |
EUR 162.5 |
ND-75 Antibody |
abx300635-50g |
Abbexa |
50 µg |
EUR 250 |
cdc25A (Ab-75) |
ANTY021163 |
Antagene |
100ug |
EUR 259 |
Antitumor agent-75 |
HY-151295 |
MedChemExpress |
Get quote |
Ask for price |
Description: Antitumor agent-75 is a novel potent antitumor agent. Antitumor agent-75 has cytotoxic effects on cancer and normal human cell lines. Antitumor agent-75 shows a highly selective cytotoxic effect against human lung adenocarcinoma (cell line A549) when combined with Antitumor agent-74 (HY-151292), the IC50 value of 2.8 μM. Antitumor agent-75 can be used for the research of cancer[1]. |
EGFR-IN-75 |
HY-152144 |
MedChemExpress |
Get quote |
Ask for price |
Description: EGFR-IN-75 is an EGFRWT and EGFRT790M inhibitor with IC50 values of 0.28 μM and 5.02 μM, respectively. EGFR-IN-75 shows anticancer and antioxidant activity[1]. |
Antifungal agent 75 |
HY-156252 |
MedChemExpress |
Get quote |
Ask for price |
Description: Antifungal agent 75 (compound 6r) is a potent antifungal agent against Candida albicans. Antifungal agent 75 significantly inhibits the formation of C. albicans biofilm, increases the permeability of the cell membrane, reduces the ergosterol level of the cell membrane, damages the membrane structure, and destroys the integrity of the cell structure to exert excellent antifungal activity[1]. |
PIK-75 (hydrochloride) |
HY-13281 |
MedChemExpress |
100mg |
EUR 171 |
Description: PIK-75 hydrochloride is a reversible DNA-PK and p110α-selective inhibitor, which inhibits DNA-PK, p110α and p110γ with IC50s of 2, 5.8 and 76 nM, respectively. PIK-75 hydrochloride inhibits p110α >200-fold more potently than p110β (IC50=1.3 μM)[1][2]. PIK-75 hydrochloride induces apoptosis[3]. |
Anticancer agent 75 |
HY-147971 |
MedChemExpress |
Get quote |
Ask for price |
Description: Anticancer agent 75 is a potent anticancer agent. Anticancer agent 75 shows cytotoxicity and selectivity in cancer cell lines. Anticancer agent 75 shows cytotoxicity to normal human kidney cell lines is at least 35 times lower than that of the Doxorubicin standard. Anticancer agent 75 shows good activity of antiplasmodial[1]. |
Antibacterial agent 75 |
HY-144621 |
MedChemExpress |
Get quote |
Ask for price |
Description: Antibacterial agent 75 (compound 24) is an antibacterial agent. Antibacterial agent 75 (compound 24) is able to re-sensitize VRSA to vancomycin[1]. |
Selenomethionine Se 75 |
MBS5784110-5mg |
MyBiosource |
5(mg |
EUR 915 |
Selenomethionine Se 75 |
MBS5784110-5x5mg |
MyBiosource |
5x5(mg |
EUR 3970 |
Grp 75 Standard |
MBS483003-03mL |
MyBiosource |
0.3mL |
EUR 285 |
Grp 75 Standard |
MBS483003-5x03mL |
MyBiosource |
5x0.3mL |
EUR 1045 |
Cytokeratin 75 antibody |
MBS5301122-01mL |
MyBiosource |
0.1mL |
EUR 750 |
Cytokeratin 75 antibody |
MBS5301122-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3215 |
C-75 Trans |
MBS3841024-5x50mg |
MyBiosource |
5x50mg |
EUR 3630 |
ND-75 Antibody |
MBS7000079-005mg |
MyBiosource |
0.05mg |
EUR 190 |
ND-75 Antibody |
MBS7000079-01mg |
MyBiosource |
0.1mg |
EUR 270 |
ND-75 Antibody |
MBS7000079-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
NubO (68-75) |
MBS8246840-5x10mg |
MyBiosource |
5x10mg |
EUR 2435 |
Cytokeratin 75 antibody |
MBS839474-01mL |
MyBiosource |
0.1mL |
EUR 750 |
Cytokeratin 75 antibody |
MBS839474-5x01mL |
MyBiosource |
5x0.1mL |
EUR 3215 |
Sephadex G 75 |
PC2030-500 |
ApexBio |
500mg |
EUR 40 |
Potassium laurate 75% |
P23250 |
Pfaltz & Bauer |
5G |
EUR 69.75 |
|
Description: CAS N° 10124-65-9 |
Phorone 70-75% |
P16690 |
Pfaltz & Bauer |
1G |
EUR 139.82 |
|
Description: CAS N° 504-20-1 |
Sephadex G-75 |
Se-492C |
Creative BioMart |
100 g |
EUR 992 |
Description: Chromatography Reagents |
Superdex 75 Increase |
Su-322P |
Creative BioMart |
each |
EUR 5440 |
Description: Chromatography Reagents |
Selenomethionine Se 75 |
T34608-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: Selenomethionine Se 75 |
Selenomethionine Se 75 |
T34608-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: Selenomethionine Se 75 |
Selenomethionine Se 75 |
T34608-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: Selenomethionine Se 75 |
Selenomethionine Se 75 |
T34608-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: Selenomethionine Se 75 |
Selenomethionine Se 75 |
T34608-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: Selenomethionine Se 75 |
PIK-75 hydrochloride |
T2287-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: PIK-75 hydrochloride |
PIK-75 hydrochloride |
T2287-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: PIK-75 hydrochloride |
PIK-75 hydrochloride |
T2287-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: PIK-75 hydrochloride |
PIK-75 hydrochloride |
T2287-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: PIK-75 hydrochloride |
PIK-75 hydrochloride |
T2287-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: PIK-75 hydrochloride |
Antibacterial agent 75 |
T61799-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: Antibacterial agent 75 |
Antibacterial agent 75 |
T61799-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: Antibacterial agent 75 |
Antibacterial agent 75 |
T61799-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: Antibacterial agent 75 |
Antibacterial agent 75 |
T61799-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: Antibacterial agent 75 |
Antibacterial agent 75 |
T61799-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: Antibacterial agent 75 |
Antitumor agent-75 |
T62510-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: Antitumor agent-75 |
Antitumor agent-75 |
T62510-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: Antitumor agent-75 |
Antitumor agent-75 |
T62510-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: Antitumor agent-75 |
Antitumor agent-75 |
T62510-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: Antitumor agent-75 |
Antitumor agent-75 |
T62510-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: Antitumor agent-75 |
Anticancer agent 75 |
T60998-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
Description: Anticancer agent 75 |
Anticancer agent 75 |
T60998-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
Description: Anticancer agent 75 |
Anticancer agent 75 |
T60998-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
Description: Anticancer agent 75 |
Anticancer agent 75 |
T60998-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
Description: Anticancer agent 75 |
Anticancer agent 75 |
T60998-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
Description: Anticancer agent 75 |
Cancer of the bladder, 75 cases (1.1mm)HumanUrinary systemBladderMalignant |
BLC1501 |
Pantomics |
1 |
EUR 352 |
Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75) |
MBS1158376-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1050 |
Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75) |
MBS1158376-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 635 |
Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75) |
MBS1158376-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 805 |
Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75) |
MBS1158376-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 735 |
Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75) |
MBS1158376-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 940 |
Recombinant Caenorhabditis elegans Putative cuticle collagen 75 (col-75) |
MBS1281221-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1165 |
Recombinant Caenorhabditis elegans Putative cuticle collagen 75 (col-75) |
MBS1281221-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 805 |
Recombinant Caenorhabditis elegans Putative cuticle collagen 75 (col-75) |
MBS1281221-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 955 |
Recombinant Caenorhabditis elegans Putative cuticle collagen 75 (col-75) |
MBS1281221-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 965 |
Recombinant Caenorhabditis elegans Putative cuticle collagen 75 (col-75) |
MBS1281221-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 1120 |
Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75) |
MBS1233273-002mgBaculovirus |
MyBiosource |
0.02mg(Baculovirus) |
EUR 1050 |
Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75) |
MBS1233273-002mgEColi |
MyBiosource |
0.02mg(E-Coli) |
EUR 635 |
Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75) |
MBS1233273-002mgYeast |
MyBiosource |
0.02mg(Yeast) |
EUR 805 |
Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75) |
MBS1233273-01mgEColi |
MyBiosource |
0.1mg(E-Coli) |
EUR 735 |
Recombinant Equine herpesvirus 1 Uncharacterized gene 75 protein (75) |
MBS1233273-01mgYeast |
MyBiosource |
0.1mg(Yeast) |
EUR 940 |
In this work, we model the basic error-call from ONT to read to inform simulation sequence with similar characteristics. We show the performance NanoSim on publicly available datasets generated using chemical R7.3 and R7 and different sequencing kit and compare the resulting synthetic sounds with other old-order simulator and experimental ONT read. We hope NanoSim have a role that allows the field and the benefits of the development of next-generation technology for nanopore sequencing scalable long reads, including genome assembly, mutation detection, and even a metagenomic analysis software.